ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,311, issued on July 28, was assigned to William Robert Arathoon Living Trust Dated August 29, 2016 (Tiburon, Calif.).
"Anti-MDR1 antibodies and uses thereof" was invented by William Robert Arathoon (Tiburon, Calif.), Raffaella Briante (Burlingame, Calif.), Suchismita Mohanty (San Bruno, Calif.), Paul David Ponath (San Francisco), Qianting Zhai (South San Francisco, Calif.) and Pingping Zhang (Cupertino, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies that target the cellular efflux pump MDR1. Also provided are pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that include or enc...